A three-gene expression signature model for risk stratification of patients with neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 27
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Times cited: 32